The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Microalbuminuria and Cardiovascular Disease
Abstract
To reduce the burden of cardiovascular disease (CVD), management strategies are increasingly focusing on preventive measures following early detection of markers of atherosclerosis. This review focuses on microalbuminuria, which is gaining recognition as a simple marker of an atherogenic milieu. Prospective and epidemiologic studies have found that microalbuminuria is predictive, independently of traditional risk factors, of all-cause and cardiovascular mortality and CVD events within groups of patients with diabetes or hypertension, and in the general population. The pathophysiologic mechanism underlying the association between albumin excretion and CVD is not fully defined. One hypothesis is that microalbuminuria may be a marker of CVD risk because it reflects subclinical vascular damage in the kidneys and other vascular beds. It may also signify systemic endothelial dysfunction that predisposes to future cardiovascular events. Based on this theory, periodic screening for microalbuminuria could allow early identification of vascular disease and help stratify overall cardiovascular risk, especially in patients with risk factors such as hypertension or diabetes. A positive test for urinary albumin excretion could signify the need for an intensive multifactorial intervention strategy, including behavior modification and targeted pharmacotherapy, aimed at preventing further renal deterioration and improving the overall CVD risk factor profile. Data from intervention studies suggest that treatment with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers, statins, and/or strict glycemic control (in diabetics) offer significant reductions in cardiovascular and/or renal morbidity in patients with albuminuria. Use of this (old) marker may allow improved use of medications and strategies for secondary prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., & Raz, I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011303 · Cited by 5,987
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Parving, H., Lehnert, H., Brøchner‐Mortensen, J., Gomis, R., Andersen, S., & Arner, P. (2001) · PubMed · Cited by 2,535
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440
(2000) · PubMed · Cited by 2,095
Diabetic nephropathy: diagnosis, prevention, and treatment
Gross, J. L., de Azevedo, M. J., Silveiro, S. P., Canani, L. H., Caramori, M. L., & Zelmanovitz, T. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.164 · Cited by 1,839
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474
Albuminuria reflects widespread vascular damage: The Steno hypothesis
Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T., & Kofoed-Enevoldsen, A. (1989) · Diabetologia · doi:10.1007/bf00285287 · Cited by 1,400
(2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.03.003 · Cited by 1,245
American Diabetes Association (2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s79 · Cited by 1,042
Chronic Kidney Disease Awareness, Prevalence, and Trends among U.S. Adults, 1999 to 2000
Coresh, J., Byrd-Holt, D., Astor, B. C., Briggs, J. P., Eggers, P. W., Lacher, D. A., & Hostetter, T. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070539 · Cited by 842
Ärnlöv, J., Evans, J. C., Meigs, J. B., Wang, T. J., Fox, C. S., Levy, D., Benjamin, E. J., D’Agostino, R. B., & Vasan, R. S. (2005) · Circulation · doi:10.1161/circulationaha.105.538132 · Cited by 736
Klausen, K., Borch-Johnsen, K., Feldt-Rasmussen, B., Jensen, G., Clausen, P., Scharling, H., Appleyard, M., & Jensen, J. S. (2004) · Circulation · doi:10.1161/01.cir.0000133312.96477.48 · Cited by 693
Stehouwer, C. D. A., Gall, M.-A., Twisk, J. W. R., Knudsen, E., Emeis, J. J., & Parving, H.-H. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1157 · Cited by 652
Ibsen, H., Olsen, M. H., Wachtell, K., Borch-Johnsen, K., Lindholm, L. H., Mogensen, C. E., Dahlöf, B., Devereux, R. B., de Faire, U., Fyhrquist, F., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000154082.72286.2a · Cited by 562
Effects of Fosinopril and Pravastatin on Cardiovascular Events in Subjects With Microalbuminuria
Asselbergs, F. W., Diercks, G. F. H., Hillege, H. L., van Boven, A. J., Janssen, W. M. T., Voors, A. A., de Zeeuw, D., de Jong, P. E., van Veldhuisen, D. J., & van Gilst, W. H. (2004) · Circulation · doi:10.1161/01.cir.0000146378.65439.7a · Cited by 523
Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey
Jones, C. A., Francis, M. E., Eberhardt, M. S., Chavers, B., Coresh, J., Engelgau, M., Kusek, J. W., Byrd-Holt, D., Narayan, K. M. V., Herman, W. H., et al. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.31388 · Cited by 444
Urinary Albumin Excretion: An Independent Predictor of Ischemic Heart Disease
Borch-Johnsen, K., Feldt-Rasmussen, B., Strandgaard, S., Schroll, M., & Jensen, J. S. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.8.1992 · Cited by 437
Microalbuminuria and Risk for Cardiovascular Disease: Analysis of Potential Mechanisms
Stehouwer, C. D. A., & Smulders, Y. M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121288 · Cited by 428
Microalbuminuria as an Early Marker for Cardiovascular Disease
de Zeeuw, D., Parving, H.-H., & Henning, R. H. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050517 · Cited by 399
Viberti, G. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510280037029 · Cited by 381
Jager, A., Kostense, P. J., Ruhé, H. G., Heine, R. J., Nijpels, G., Dekker, J. M., Bouter, L. M., & Stehouwer, C. D. A. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.617 · Cited by 365
Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril
Heeg, J. E., de Jong, P. E., van der Hem, G. K., & de Zeeuw, D. (1989) · Kidney International · doi:10.1038/ki.1989.190 · Cited by 363
Use of the Albumin/Creatinine Ratio to Detect Microalbuminuria: Implications of Sex and Race
Mattix, H. J., Hsu, C.-Y., Shaykevich, S., & Curhan, G. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1341034 · Cited by 355
Schram, M. T., Chaturvedi, N., Schalkwijk, C. G., Fuller, J. H., Stehouwer, C. D. A., & EURODIAB Prospective Complications Study Group (2005) · Diabetologia · doi:10.1007/s00125-004-1628-8 · Cited by 282
Romundstad, S., Holmen, J., Kvenild, K., Hallan, H., & Ellekjær, H. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00742-x · Cited by 270
Rossing, K., Schjoedt, K. J., Jensen, B. R., Boomsma, F., & Parving, H.-H. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00511.x · Cited by 225
Rossing, K., Jacobsen, P., Pietraszek, L., & Parving, H.-H. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2268 · Cited by 225
Jensen, J. S., Borch-Johnsen, K., Jensen, G., & Feldt-Rasmussen, B. (1995) · Clinical Science · doi:10.1042/cs0880629 · Cited by 220
Screening, Monitoring, and Treatment of Albuminuria: Public Health Perspectives
de Jong, P. E., & Curhan, G. C. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010097 · Cited by 218
Stehouwer, C. D. A., Henry, R. M. A., Dekker, J. M., Nijpels, G., Heine, R. J., & Bouter, L. M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09211.x · Cited by 211
A 15.5-Year Follow-up Study of Stroke in a Japanese Provincial City: The Shibata Study
Nakayama, T., Date, C., Yokoyama, T., Yoshiike, N., Yamaguchi, M., & Tanaka, H. (1997) · Stroke · doi:10.1161/01.str.28.1.45 · Cited by 206
Buter, H. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/13.7.1682 · Cited by 199
Effect of Pravastatin on Rate of Kidney Function Loss in People With or at Risk for Coronary Disease
Tonelli, M., Isles, C., Craven, T., Tonkin, A., Pfeffer, M. A., Shepherd, J., Sacks, F. M., Furberg, C., Cobbe, S. M., Simes, J., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.517565 · Cited by 197
Yuyun, M. F. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh008 · Cited by 192
Gambaro, G., Kinalska, I., Oksa, A., Pont’uch, P., Hertlová, M., Olsovsky, J., Manitius, J., Fedele, D., Czekalski, S., Perusicová, J., et al. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000014254.87188.e5 · Cited by 192
Tonolo, G., Ciccarese, M., Brizzi, P., Puddu, L., Secchi, G., Calvia, P., Atzeni, M. M., Melis, M. G., & Maioli, M. (1997) · Diabetes Care · doi:10.2337/diacare.20.12.1891 · Cited by 168
Microalbuminuria and cardiovascular risk
Karalliedde, J. J., & Viberti, G. C. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2004.08.010 · Cited by 167
Liu, J. E., Robbins, D. C., Palmieri, V., Bella, J. N., Roman, M. J., Fabsitz, R. R., Howard, B. V., Welty, T. K., Lee, E. T., & Devereux, R. B. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00403-0 · Cited by 149
Wachtell, K., Palmieri, V., Olsen, M. H., Bella, J. N., Aalto, T., Dahlöf, B., Gerdts, E., Wright, J. T., Papademetriou, V., Mogensen, C. E., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.119895 · Cited by 142
Brantsma, A. H., Bakker, S. J. L., Hillege, H. L., de Zeeuw, D., de Jong, P. E., Gansevoort, R. T., & the PREVEND Study Group (2005) · Diabetes Care · doi:10.2337/diacare.28.10.2525 · Cited by 141
Ray, K. K., Cannon, C. P., Cairns, R., Morrow, D. A., Rifai, N., Kirtane, A. J., McCabe, C. H., Skene, A. M., Gibson, C. M., Ridker, P. M., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.024 · Cited by 130
Thobari, J. A., Asselbergs, F. W., Boersma, C., de Vries, R., Hillege, H. L., van Gilst, W. H., Gansevoort, R. T., de Jong, P. E., den Berg, L. T. W. D. J., & Postma, M. J. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.03.012 · Cited by 130
Jager, A., van Hinsbergh, V. W. M., Kostense, P. J., EMEIS, J. J., Nijpels, G., Dekker, J. M., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000013786.80104.d4 · Cited by 128
Diercks, G. F. H., van Boven, A. J., Hillege, H. L., Janssen, W. M., Kors, J. A., de Jong, P. E., Grobbee, D. E., Crijns, H. J., & van Gilst, W. H. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2248 · Cited by 127
Left ventricular geometry and function in patients with essential hypertension and microalbuminuria
Pontremoli, R., Ravera, M., Bezante, G. P., Viazzi, F. C., Nicolella, C., Berruti, V., Leoncini, G., Sette, M. D., Brunelli, C., Tomolillo, C., et al. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917070-00016 · Cited by 116
Yuyun, M. F., Khaw, K., Luben, R., Welch, A. A., Bingham, S. A., Day, N., & Wareham, N. J. (2004) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01264.x · Cited by 107
Comper, W. D., Jerums, G., & Osicka, T. M. (2003) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2003.10.008 · Cited by 103
Palmer, A. J., Annemans, L., Roze, S., Lamotte, M., Lapuerta, P., Chen, R. K., Gabriel, S., Carita, P., Rodby, R. A., de Zeeuw, D., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1897 · Cited by 97
Microalbuminuria in Type 2 Diabetics: An Important, Overlooked Cardiovascular Risk Factor
Weir, M. R. (2004) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2004.02524.x · Cited by 91
Self-citationNakamura, T., Ushiyama, C., Hirokawa, K., Osada, S., Shimada, N., & Koide, H. (2001) · American Journal of Nephrology · doi:10.1159/000046648 · Cited by 86
Microalbuminuria in Ischemic Stroke
Beamer, N. B., Coull, B. M., Clark, W. M., & Wynn, M. (1999) · Archives of Neurology · doi:10.1001/archneur.56.6.699 · Cited by 82
Leoncini, G., Sacchi, G., Viazzi, F. C., Ravera, M., Parodi, D., Ratto, E., Vettoretti, S., Tomolillo, C., Deferrari, G., & Pontremoli, R. (2002) · Journal of Hypertension · doi:10.1097/00004872-200207000-00018 · Cited by 73
Stuveling, E. M., Hillege, H. L., Bakker, S. J. L., Asselbergs, F. W., de Jong, P. E., Gans, R. O. B., & de Zeeuw, D. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00252-1 · Cited by 62
Diercks, G. F. H., Hillege, H. L., van Boven, A., Kors, J. A., Crijns, H. J. G. M., Grobbee, D. E., de Jong, P. E., & van Gilst, W. H. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02165-4 · Cited by 53
Nosadini, R., Velussi, M., Brocco, E., Abaterusso, C., Piarulli, F., Morgia, G., Satta, A. E., Faedda, R., Abhyankar, A., Luthman, H., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.1.228 · Cited by 36
Koulouris, S. N., Lekatsas, I., Karabinos, I. K., Ioannidis, G., Katostaras, T., KRANIDIS, A. J., Triantafyllou, K. A., Thalassinos, N., & Anthopoulos, L. P. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.07.031 · Cited by 35
Cost-effective strategies in the prevention of diabetic nephropathy
Rippin, J., Barnett, A., & Bain, S. (2004) · PharmacoEconomics (Auckland) · doi:10.2165/00019053-200422010-00002 · Cited by 29
Cited by
Ndumele, C. E., Neeland, I. J., Tuttle, K. R., Chow, S. L., Mathew, R. O., Khan, S. S., Coresh, J., Baker-Smith, C. M., Carnethon, M. R., Després, J.-P., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001186 · Cited by 1,405
Shift work and cardiovascular disease – pathways from circadian stress to morbidity
Puttonen, S., Härmä, M., & Hublin, C. (2010) · Scandinavian Journal of Work, Environment & Health · doi:10.5271/sjweh.2894 · Cited by 560
“The same holds true for microalbuminuria, which is a risk marker for arterial thromboembolism (75) and a predictor of CVD mortality and cardiac events (76).”
BackgroundPsoriasis Severity and the Prevalence of Major Medical Comorbidity: A Population-Based Study
Yeung, H., Takeshita, J., Mehta, N. N., Kimmel, S. E., Ogdie, A., Margolis, D. J., Shin, D. B., Attor, R., Troxel, A. B., & Gelfand, J. M. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.5015 · Cited by 464
Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity
Bakker, W., Eringa, E. C., Sipkema, P., & van Hinsbergh, V. W. M. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0685-6 · Cited by 343
Albuminuria in chronic heart failure: prevalence and prognostic importance
Jackson, C. E., Solomon, S. D., Gerstein, H. C., Zetterstrand, S., Olofsson, B., Michelson, E. L., Granger, C. B., Swedberg, K., Pfeffer, M. A., Yusuf, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61378-7 · Cited by 308
Metadata
- Authors
- Weir, M. R.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2007-05
- Volume
- 2
- Issue
- 3
- Pages
- 581-590
- ISSN
- 1555-9041 (ISSN-L)
- OpenAlex
- W2162061026
- Cited by
- 342
- References
- 64
- FWCI
- 15.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.